15, 2025 Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows
There is no dose adjustment mechanismthe entire pen contents deliver the labeled dose
And then it also slows gastric emptying, which as you know, leads to greater feelings of fullness
He is one of the most highly regarded experts on treatments for obesity, having done some of the most important research on very low-calorie diets, a variety of medications, bariatric surgery, intervention in primary care settings, and more
Look at both the monthly payment and total cost over time, not just the lowest monthly number
Continuous glucose monitoring may be beneficial during the transition period for some patients